Thar Pharmaceuticals, Inc.
Records under this name other than patents Thar Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Thar Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,399,023 | Crystallization method and bioavailability Formerly held Lapsed on the fee record Ended Mar 19, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 19, 2025 | From the USPTO record |
| US 8,389,512 | In vivo studies of crystalline forms of meloxicam Formerly held Lapsed on the fee record Ended Mar 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Mar 5, 2025 | From the USPTO record |
| US 9,340,565 | Crystalline forms Formerly held Lapsed on the fee record Ended May 17, 2024 · From the USPTO record | Lapsed on the fee record | Ended May 17, 2024 | From the USPTO record |
| US 9,334,296 | Crystallization method and bioavailability Formerly held Lapsed on the fee record Ended May 10, 2024 · From the USPTO record | Lapsed on the fee record | Ended May 10, 2024 | From the USPTO record |
| US 8,124,603 | In vivo studies of crystalline forms of meloxicam Formerly held Lapsed on the fee record Ended Feb 28, 2024 · From the USPTO record | Lapsed on the fee record | Ended Feb 28, 2024 | From the USPTO record |
| US 10,519,176 | Crystalline forms Formerly held Lapsed on the fee record Ended Dec 31, 2023 · From the USPTO record | Lapsed on the fee record | Ended Dec 31, 2023 | From the USPTO record |
| US 9,169,279 | Crystallization method and bioavailability Formerly held Lapsed on the fee record Ended Oct 27, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 27, 2023 | From the USPTO record |
| US 10,323,052 | Crystallization method and bioavailability Formerly held Lapsed on the fee record Ended Jun 18, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 18, 2023 | From the USPTO record |
| US 9,040,535 | Crystalline molecular comlpexes of tadalafil Formerly held Lapsed on the fee record Ended May 26, 2023 · From the USPTO record | Lapsed on the fee record | Ended May 26, 2023 | From the USPTO record |
| US 8,980,868 | Oral forms of a phosphonic acid derivative Formerly held Lapsed on the fee record Ended Mar 17, 2023 · From the USPTO record | Lapsed on the fee record | Ended Mar 17, 2023 | From the USPTO record |